Agreement termination notice period.

No definition available.

Name:	sptx_AgreementTerminationNoticePeriod
Namespace Prefix:	sptx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Award agreement first phase of research committed funding amount.

+ References

No definition available.

+ Details

Name:	sptx_AwardAgreementFirstPhaseOfResearchCommittedFundingAmount
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Award agreement maximum funding amount.

+ References

No definition available.

+ Details

Name:	sptx_AwardAgreementMaximumFundingAmount
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Award agreement second phase of research maximum uncommitted funding amount.

+ References

No definition available.

+ Details

Name:	sptx_AwardAgreementSecondPhaseOfResearchMaximumUncommittedFundingAmount
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Initial term of agreement.

+ References

No definition available.

+ Details

Name:	sptx_InitialTermOfAgreement
Namespace Prefix:	sptx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License and collaboration agreement.

+ References

No definition available.

+ Details

Name:	sptx_LicenseAndCollaborationAgreementLineItems
Namespace Prefix:	sptx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum amount of successful commercial milestones per licensed product.

+ References

No definition available.

+ Details

Name:	sptx_MaximumAmountOfSuccessfulCommercialMilestonesPerLicensedProduct
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Maximum amount of successful development milestones per licensed product.

+ References

No definition available.

+ Details

Name:	sptx_MaximumAmountOfSuccessfulDevelopmentMilestonesPerLicensedProduct
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Milestones payment earned.

+ References

No definition available.

+ Details

Name:	sptx_MilestonesPaymentEarned
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Payment of development milestones.

+ References

No definition available.

+ Details

Name:	sptx_PaymentOfDevelopmentMilestones
Namespace Prefix:	sptx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage on net sales.

+ References

No definition available.

+ Details

Name:	sptx_PercentageOnNetSales
Namespace Prefix:	sptx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-18

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479532/912-730-25-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=sptx_MonashLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=sptx_MonashCollaborationAgreementAndAdvancedResearchProjectsAgencyForHealthAwardMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License and Collaboration Agreement - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended
	Mar. 31, 2024	Apr. 30, 2024	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
License And Collaboration Agreement [Line Items]
Research and development expense			$ 21,431,000	$ 10,534,000
Prepaid and other current assets			5,736,000		$ 7,247,000
Monash License Agreement
License And Collaboration Agreement [Line Items]
Payment of development milestones	$ 200,000	$ 100,000	0
Maximum amount of successful development milestones per licensed product		1,075,000.000
Maximum amount of successful commercial milestones per licensed product		$ 7,250,000
Monash License Agreement \| Maximum
License And Collaboration Agreement [Line Items]
Percentage on net sales		5.00%
Monash License Agreement \| Minimum
License And Collaboration Agreement [Line Items]
Percentage on net sales		3.00%
Monash Collaboration Agreement and ARPA-H Award
License And Collaboration Agreement [Line Items]
Award agreement, maximum total funding amount			15,200,000
Award agreement, first phase of research committed funding amount			3,500,000
Award agreement second phase of research maximum uncommitted funding amount			$ 11,700,000
Initial term of agreement			48 months
Agreement termination notice period			60 days
Milestones payment earned			$ 0